Tci Wealth Advisors, Inc. Catalent, Inc. Transaction History

Tci Wealth Advisors, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$45.44 - $74.26 $1,908 - $3,118	-42 Reduced 22.46%	145 $9,000
Q4 2022 Feb 06, 2023	BUY	$41.39 - $81.0 $6,167 - $12,069	149 Added 392.11%	187 $8,000
Q3 2022 Nov 08, 2022	SELL	$72.36 - $113.1 $2,460 - $3,845	-34 Reduced 47.22%	38 $3,000
Q2 2022 Jul 19, 2022	BUY	$87.2 - $114.05 $872 - $1,140	10 Added 16.13%	72 $8,000
Q1 2022 Apr 29, 2022	SELL	$94.19 - $124.49 $9,795 - $12,946	-104 Reduced 62.65%	62 $7,000
Q4 2021 Jan 24, 2022	SELL	$119.57 - $139.07 $2,032 - $2,364	-17 Reduced 9.29%	166 $21,000
Q3 2021 Oct 29, 2021	BUY	$109.17 - $142.35 $2,401 - $3,131	22 Added 13.66%	183 $24,000
Q2 2021 Aug 02, 2021	BUY	$100.34 - $115.69 $7,826 - $9,023	78 Added 93.98%	161 $17,000
Q1 2021 Apr 29, 2021	BUY	$101.51 - $125.27 $4,973 - $6,138	49 Added 144.12%	83 $9,000
Q4 2020 Jan 21, 2021	BUY	$85.88 - $105.36 $1,717 - $2,107	20 Added 142.86%	34 $4,000
Q3 2020 Oct 20, 2020	SELL	$72.74 - $92.5 $4,291 - $5,457	-59 Reduced 80.82%	14 $1,000
Q4 2019 Jan 27, 2020	BUY	$47.06 - $56.64 $2,305 - $2,775	49 Added 204.17%	73 $4,000
Q3 2019 Oct 17, 2019	BUY	$47.45 - $58.05 $1,138 - $1,393	24 New	24 $1,000

511

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.